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ABSTRACT
Tetralogy of Fallot (TOF) is the most common cyanotic congenital heart defect. 
Postoperative patients with TOF are mostly compromised by chronic 
pulmonary regurgitation and chronic right ventricular volume load. These 
patients suffer from impaired exercise capacity and have an increased risk of 
sudden cardiac death (SCD) and heart failure.  
This thesis investigates the long-term outcome of surgically corrected TOF 
patients in a population-based setting. It also assesses the effects of long-
lasting pulmonary regurgitation (PR) in the postoperative state in children and 
adolescents with TOF and healthy control subjects.  
During the period from 1962 to 2007 a total of 600 patients with TOF were 
surgically corrected in Finland before the age of 15 years. The follow-up time 
of these patients was 23±12.1 years. We observed that: 
i. 514 (85%) patients were alive and living in Finland; 82 (14%) had died. 
Primary repair of TOF was found to predict lower mortality and longer 
event-free survival when compared with two-stage repair. The need for 
a transannular patch (TAP) in TOF surgery carried a higher risk of re-
operation without impact on late survival. 
 
In addition to the population-based follow-up study, we conducted a 
single-centre cross-sectional study including 45 patients after repair of 
tetralogy of Fallot (rTOF) and 45 healthy age- and gender-matched paediatric 
and adolescent volunteers as controls (CO). Cardiac magnetic resonance 
(CMR) imaging was performed on all the study subjects. We made the 
following observations: 
ii. Late gadolinium enhancement (LGE), detected with CMR after 
gadolinium contrast agent, was also found outside the surgically 
affected areas in the right ventricle (RV) of TOF patients. Severity of PR 
correlated with the degree of LGE. LGE is recognized as a marker of 
fibrosis, scars, or otherwise abnormal myocardium. 
iii. In children and adolescents with TOF, severe pulmonary regurgitation 
importantly affects volume flow through the left atrium. Reduction in 
left ventricular (LV) preload volume may be an additional factor 
contributing to LV dysfunction. 
iv. RV longitudinal strain is increased in paediatric TOF patients with 
severe pulmonary regurgitation. In comparison with healthy 
volunteers, all TOF patients demonstrated enhanced and delayed RV 
circumferential strain that was accentuated in the apical region. 
In conclusion, the late results of TOF surgery are excellent. Patients operated 
on in the last two decades can expect to have a life expectancy comparable to 
their healthy peers. Early primary correction and avoidance of TAP if possible 
are predictors of superior late outcome.  
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Chronic pulmonary regurgitation has deleterious effects on both right and LV 
filling and function. Novel methods such as LGE analysis, feature tracking 
(FT), and evaluation of LV preload may prove valuable when assessing the 
need for pulmonary valve replacement (PVR).
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YHTEENVETO SUOMEKSI (FINNISH 
SUMMARY)
Sydämen rakennevika on kaikkein yleisin yhteen elimeen kohdistuva 
rakennevika. Rakenteellinen sydänvika todetaan n. 1 %:lla vastasyntyneistä. 
Potilaiden ennuste on parantunut huomattavasti viime vuosikymmenien 
aikana, ja aikuisiän on saavuttanut jo yli 7000 sydänlasta. Hyvästä 
ennusteesta ovat poikkeuksena kuitenkin syanoottiset sydänviat, joilla 
tarkoitetaan ryhmää synnynnäisiä sydänvikoja, joissa sydämen oikean ja 
vasemman puolen välillä on oikovirtaus aiheuttaen verenkierron 
happivajausta ja sinisyyttä. Kun muiden rakenteellisten sydänvikojen ennuste 
alkaa lähentyä verrokkiväestöä, oikeaa kammiota kuormittavien syanoottisten 
sydänvikojen ennuste on edelleenkin merkittävästi verrokkiväestö huonompi, 
ja potilailla on normaaliväestöä suurempi riski kuolla joko sydämen 
vajaatoiminnan tai sydänperäisen äkkikuoleman vuoksi. Yleisyydeltään 
suurin ja merkittävin syanoottinen sydänvika on Fallot'n tetralogia. 
Tutkimuksessa käytettiin koko väestön kattavaa synnynnäisten 
sydänvikojen rekisteriä, jonka avulla kaikkien Suomessa leikattujen Fallot-
potilaiden sairastuvuutta, kuolleisuutta sekä erilaisten kirurgisten 
menetelmien vaikutusta myöhäistätuloksiin voitiin selvittää. Otimme 
tutkimukseen mukaan kaikki Suomessa alle 15-vuotiaana korjausleikatut 
Fallot-potilaat, joita oli yhteensä 601. Rekisterin tietoja käyttämällä ja niitä 
väestörekisteriin ja potilasasiakirjoihin yhdistämällä selvitimme 99,8% 
kattavuudella potilaiden myöhäistuloksen sekä merkittävältä osalta myös 
käytetyt kirurgiset menetelmät sekä uusintaleikkausten määrän. Lisäksi 
tutkimme kliinisessä potilas-verrokkiasetelmassa Fallot-lapsia ja nuoria sekä 
heidän ikäisiään terveitä verrokkihenkilöitä. Tavoitteena oli selvittää sydämen 
magneettikuvaksella Fallot-potilaiden sydämen toimintaa ja vajaatoiminnan 
kehittymislöydöksiä lapsuus- ja nuoruusiässä. Erityisenä mielenkiinnon 
kohteenamme oli Fallot-potilaille tyypillisen keuhkovaltimoläpän vuodon 
merkitys sydämen toiminnan ja rakenteellisten muutosten taustalla. 
Kliinisessä potilaskohortissamme tutkimme yhteensä neljäkymmentäviisi 7-
19-vuotiasta Fallot-potilasta sekä 48 tervettä saman ikäistä verrokkihenkilöä. 
Tutkimuspotilaat tutkittiin vuosina 2008-2012. 
Tutkimuksessa osoitettiin, että Fallot'n tetralogian korjaaminen käyttäen 
keuhkovaltimoläppärenkaan katkaisevaa ja sitä laajentavaa 
keinomateriaalipaikkaa aiheuttaa merkittävän keuhkovaltimoläpän vuodon ja 
kasvattaa merkittävästi potilaan riskiä joutua uusintaleikkaukseen, kun heitä 
verrattiin potilaisiin, joiden läppärengas voitiin jättää koskematta. Tämä tulos 
on tärkeä arvioitaessa käytössä olevia kirurgisia menetelmiä ja antoi meille 
mahdollisuuden arvioida suomalaisen kirurgian myöhäistuloksia eri 
leikkausmenetelmiin liittyen. Lisäksi selvisi, että primaarikorjaus ilman 
edeltävää apuleikkausta tuottaa paremman lopputuloksen, sillä potilaiden 
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kuolleisuus on merkittävästi alhaisempi ja he joutuvat selvästi harvemmin 
uusintaleikkaukseen kuin potilaat, joille on tehty palliatiivinen toimenpide 
ennen korjausta. Tämä tulos tukee vallalla olevaa käsitystä siitä, että potilaat 
tulisi pääosin pyrkiä korjaamaan ilman välivaiheen apuleikkauksia.  
Kuvantamistutkimuksessa selvisi, että keuhkojen läpi virtaava verivolyymi 
on tavallista vähäisempi Fallot-potilailla, mikä johtaa sydämen vasemman 
eteisen verenvirtauksen pienenemiseen ja alentuneeseen vasemman kammion 
esikuormaan. Esikuorma oli alentunut merkittävästi enemmän niillä 
potilailla, joilla oli vaikea keuhkovaltimoläppävuoto. Tällä havaitsemallamme 
verenkierron poikkeavuudella saattaa olla merkittävä osuus myöhemmin 
ilmaantuvan vasemman kammion vajaatoiminnan kehittymisessä. 
Esikuorman arviointi voi mahdollisesti jatkossa olla yksi menetelmä, jolla 
varhainen kehittyvä vajaatoiminta havaitaan.  
Fallot'n tetralogiaa sairastavien potilaiden sydänlihas on rakenteellisesti 
poikkeava jo lapsuusiässä. Magneettikuvauksen myöhäistehostumatekniikalla 
havaittiin, että fibroosiin viittaavia tehostuma-alueita esiintyi oikeassa 
kammiossa myös kirurgisesti operoitujen alueiden ulkopuolella. Tehostumia 
oli merkittävästi enemmän keuhkovaltimoläppävuodon vaikeutuessa, oikean 
kammion laajentuessa sekä leikkauksen jälkeisen seuranta-ajan pidentyessä. 
Myöhäistehostumien arviointi on mahdollinen tulevaisuuden menetelmä 
arvioitaessa sydänlihaksen kuntoa ja mahdollista uusintaleikkauksen tarvetta.  
Tutkimuksessa huomattiin myös, että magneettikuvauksessa käytettävä 
feature tracking (FT) strain-analyysi soveltui lapsipotilaiden sydänlihaksen 
liikehäiriöiden selvittämiseen. Liikelöydökset poikkesivat kaikilla potilailla 
terveiden verrokkien mittauksiin verrattuna. Keuhkovaltimoläppävuodon 
huomattiin vähentävän oikean kammion seinämäliikettä kuvaavia strain-
arvoja etenkin eteiskammioläppätasossa, mutta strain-arvot voimistuivat 
kompensatorisesti kohti sydämen kärkeä. FT-analyysi tarjoaa mahdollisen 
menetelmän oikean kammion vajaatoiminnan ja liikehäiriöiden varhaiseen 
tunnistamiseen ja sillä saattaa olla merkitystä arvioitaessa mahdollista 
uusintaleikkauksen tarvetta ja ajoitusta.  
Tutkimustemme mukaan Fallot-potilaiden ennuste parantunut 
merkittävästi vuosikymmenten aikana. TOF potilaille kannattaa, mikäli vain 
mahdollista, tehdä varhaislapsuudessa suora kirurginen korjaus ilman 
edeltävää oireita lievittävää leikkausta. Potilaiden hankalin myöhäisongelma 
on vaikea keuhkovaltimoläppävuoto, jonka totesimme vähentävän keuhkojen 
läpi kiertävän veren määrää ja vaikuttavan haitallisesti sydämen vasemman 
puolen toimintaan. Tämä on uusi havainto. Löysimme Fallot-potilaiden 
sydämestä arpeutumiseen viittaavia löydöksiä magneettikuvauksen 
myöhäistehostuma-tekniikalla ja totesimme löydösten liittyvän seuranta-ajan 
pituuteen ja keuhkovaltimoläpän vuodon määrään. Magneettikuvauksen 
strain-analyysilla osoitimme, että TOF-potilaiden sydänlihaksen liikkuvuus 
on poikkeavaa ja liikehäiriön vaikeusasteella on yhteys keuhkovaltimoläpän 
vuotoon. Näiden löydösten toivomme tuovan lisäinformaatiota Fallot-
potilaiden lääketieteelliseen seurantaan, joko suoraan käytettynä tai osana 
Introduction 
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tulevaisuudessa mahdollisesti kehitettäviä algoritmejä, jotka hyödyntävät ja 
analysoivat laaja-alaisesti potilaasta tutkittuja muuttujia. Kummassakin 
tapauksessa ne voisivat auttaa hoitavia lääkäreitä jatkohoitoon ja 
uusintaleikkauksiin liittyvässä päätöksenteossa.  
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1 INTRODUCTION
The congenital heart defect TOF is obseved in 3% to 6% of every 10 000 births 
and is the most common cyanotic congenital heart defect. Before the era of 
corrective surgery, only half of TOF patients survived the first years of life and 
only a few reached adulthood.  
In 1954 Lillehei performed the first intra-cardiac repair of TOF by using 
cross-circulation. The first patient in Finland was corrected in 1960. Over 700 
patients have since been surgically corrected in Finland, and an increasing 
population of these patients have reached adult age.  
Nowadays, during the modern surgical era, most if not all patients survive 
initial surgery and can expect to have a close to normal exercise capacity in 
childhood and adolescence. Despite the drastically improved outcome of TOF 
patients during the recent decades, both internationally and in Finland, these 
patients still suffer from chronic pulmonary regurgitation. The post-operative 
course after adolescence is compromised by several complications such as 
decreased exercise capacity, rhythm disturbances, and even SCD. A re-
operation to replace the pulmonary valve is often needed during adolescence 
or early adulthood. Even though TOF has long been emphasized as a right-
sided congenital defect, the role of the left ventricle (LV) as an important 
determinant of TOF outcome has emerged in recent years. Several 
chromosomal abnormalities, most commonly trisomy 21 (Down syndrome) 
and 22q11 microdeletion, are often associated with TOF and compromise the 
outcomes of this patient group.  
 
In this thesis, we examined the late results and causes of death of TOF 
patients in Finland. The impact of surgical methods on mortality and 
morbidity was also assessed in a population-based setting. We aimed to 
investigate how chronic pulmonary regurgitation, in addition to the RV, also 
affects LV haemodynamics and myocardial function. We also studied novel 
clinical and radiological markers of cardiac morphology and function in a 
prospective patient cohort with healthy controls. 
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2 REVIEW OF THE LITERATURE
 
2.1 HISTORY AND CLINICAL FEATURES
2.1.1 HISTORY
William Harvey introduced the revolutionary concept of two separated 
circulations (systemic and pulmonary) in 1628(1). This observation served as 
the basis for the first recognition of tetralogy of Fallot (TOF), which dates back 
to 1671 in Denmark when Niels Stenson described TOF in a foetus with ectopia 
cordis(2). It took more than a century before other investigators described 
similar anatomy(3). An elegant anatomical description was illustrated by 
William Hunter in London in 1784 in his private publication “Medical 
observations and inquiries”(4). He stated:  
“…the passage from the right ventricle into the pulmonary artery, 
which should have admitted a finger, was not so wide as a goose quill; 
and there was a hole in the partition of the two ventricles, large enough 
to pass the thumb from one to the other. The greatest part of the blood 
in the right ventricle was driven with that of the left ventricle into the 
aorta, or great artery, and so lost all the advantage which it ought to 
have had from breathing”.  
Hunter described this disease as a combination of three malformations: 
ventricular septal defect, subpulmonary and pulmonary valve stenosis, and 
right ventricular (RV) hypertrophy.  
Another hallmark description was made by Ethienne-Louis Fallot in 1888 
as he proposed that there was a single pathologic foetal process that resulted 
in association of these different anatomic features (5, 6). However, the term 
“tetralogy of Fallot” was not used by him as he called this defect “la maladie 
bleue” or “cyanose cardiaque”. The term tetralogy of Fallot was established by 
Maude Abbot in Canada in 1924 and the features of this tetrad were coined 
according to four distinct anatomic features: ventricular septal defect (I) with 
over-riding of the aorta (II), RV outflow obstruction (III), and RV hypertrophy 
(IV).  
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Figure 1 Etienne-Louis Arthur Fallot (1850-1911)
 
Characteristic to this “anatomic era” of TOF was the continuously expanding 
comprehension of its anatomic and clinical features. In the early 20th century, 
many new diagnostic tools became available that were successfully 
incorporated to assist clinical cardiological practice. A remarkable clinical 
landmark was Maude Abbot’s introduction of circulatory and auscultatory 
diagrams, the chest x-ray, and findings from a TOF patient’s 
electrocardiogram in 1936(7).  
2.1.2 CLINICAL FEATURES
 
In the recent literature the anatomic features of TOF have been described 
as follows: “anterocephalad deviation of the right ventricle outlet septum or its 
fibrous remnant, combined with a malformed arrangement of the 
septoparietal trabeculations which produce an annular obstruction at the 
infundibulum”(8).  
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Figure 2 Diagrams of normal heart anatomy and TOF anatomy. Three types of 
pulmonary stenosis (supravalvar, valvar, and subvalvar) are illustrated. 
Illustration by Emma Eskola. 
 
 
 
It has been suggested that TOF results from underdevelopment of the 
subpulmonary infundibulum. The spectrum of disease is wide ranging from 
mild right ventricular outflow tract obstruction (RVOTO) to complete 
obstruction. When the outflow tract is completely obstructed, the condition 
can also be called pulmonary atresia with VSD, or “tetralogy of Fallot with 
pulmonary atresia”. The classic and most common type of TOF can be defined 
when the heart has normal segmental anatomic structure, the right ventricular 
outflow tract is patent at birth, and other significant intracardiac 
abnormalities do not coexist(8). These associated defects could for example be 
atrial septal defect (ASD) right aortic arch, atrioventricular septal defect 
(AVSD, mostly associated with Down syndrome), multiple VSDs, double outlet 
right ventricle (DORV), anomalous left anterior descending coronary artery, 
and straddling mitral valve (SMV)(9).  
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2.1.3 NATURAL HISTORY
Despite advances in diagnostics and pathological understanding in the early 
20th century, there were few options to reduce the morbidity in these children, 
who often died at a young age. In a study on the natural history of TOF 
published in 1978, 66% of patients born with the defect (including the 
pulmonary atresia variant) were alive at the age of 1 year. Remarkably, the 
instantaneous risk of death was highest in the first year of life, slowly 
decreasing until 10 years of age. At this age, however, the attrition rate remains 
relatively constant at 6.4% per year REF12. Table 1 summarizes the 
percentages of death at different ages according to the literature. 
 
Table 1. Natural survival of TOF patients [modified from Loh et al., Campbell et al. and 
Bertranou et al.(10-12)]. Rate of death from birth expressed as percent.
Age (years) Percentage of death 
1 10-34 
3 23-49 
5 33 
10 55-76 
20 84 
30 96 
 
When interpreting these results, it must be recognized that the pulmonary 
atresia variant is an anatomical variant of TOF with especially poor prognosis. 
When these patients are omitted from survival calculations, still only one third 
of the patients survive to the age of 10 years(12). The most common causes of 
death are severe hypoxemic spells (62%), cerebrovascular accidents (17%), and 
brain abscesses (13%)(10). 
2.1.4 CLINICAL PRESENTATIONS
The severity of RVOT obstruction mostly dictates the clinical features of TOF 
after birth.  Patent ductus arteriosus and collateral arteries from the systemic 
to the pulmonary side most commonly modify this picture (13). Table 2 
summarizes the different clinical presentations of TOF after birth based on the 
severity of muscular RVOT obstruction. 
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Table 2. Clinical presentations of TOF at birth (modified from Redington et al.(13))
Hypercyanotic spells are an important and often dramatic clinical feature 
of infants with TOF. These spells refer to sudden profound cyanosis and 
drowsiness that are sometimes associated with loss of consciousness. These 
bouts of deterioration can be dangerous and may result in brain injury or even 
death. Severe spells may last 15 to 60 minutes and are most commonly 
observed in infants and toddlers from 6 to 24 months of age. Other 
manifestations, such as convulsions, hyperpnoea, or very fast deep breathing 
are also possible. Hypercyanotic spells may possibly result from infundibular 
spasm (14) as a primary cause. Others suggest that these spasms are secondary 
to systemic vasodilation, reduced RV preload, dehydration, or some other 
source of sympathetic activity(13). Primary treatment of spells includes 
oxygen, pacifying the infant in knees-to-chest position with or without 
•persistent cyanosis apparent within first hours or days of life
•cyanosis is provoked when crying, feeding, and doing other activities
•metabolic acidosis resulting from arterial desaturation, compensated by 
increased respiratory rate
•in duct-dependent setting, pulmonary flow is derived from left-to-right shunt 
and from ductus arteriosus and treatment with prostaglandin E is vital
•hypercyanotic spells may occur
•acyanotic at birth
•systolic murmur usually detected in routine examination
•cyanosis develops with increasing infundibular stenosis
•cyanosis is noted within the first weeks of life, sometimes delayed
•hypercyanotic spells may occur
•mostly acyanotic
•feed poorly
•gain weight poorly
•as right ventricular hyperthrophy develops, cyanosis and other typical 
features are exhibited
 Clinical features when subpulmonary obstruction is severe
 Clinical features when subpulmonary obstruction is moderate
 Clinical features when subpulmonary obstruction is minimal
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sedation, hydration and increasing peripheral resistance with medication. 
Hypercyanotic spells may be prevented with the use beta-blockade. Surgical 
intervention or catheterization should be considered in the tertiary unit. These 
infants are considered as high-risk patients and surgery (palliative or 
corrective) is often performed in early infancy(15). 
Chromosomal anomalies are frequently diagnosed in TOF patients (25%). 
The two most common findings are trisomy 21 (Down syndrome) and 
microdeletion of the q11 region of chromosome 22 (22q11 microdeletion) (16) 
with a prevalence up to 25%(17).  
2.1.5 DIAGNOSTICS
Similar to many cyanotic and other complex congenital heart defects, TOF can 
be diagnosed during pregnancy in the second trimester morphological 
ultrasound screening scan. Antenatal detection rates are 13% to 43% (18-20). 
The foetal diagnosis is especially beneficial for foetuses with severe right 
ventricular outflow tract obstruction. In these cases, the antenatal diagnosis 
allows better planning of neonatal care and facilitates sufficiently early 
prostaglandin treatment for selected patients to avoid spontaneous closure of 
ductus arteriosus, which therefore prevents possible life-threatening postnatal 
cyanosis(8). This is particularly important for neonates whose prenatal echo 
suggests retrograde flow in the ductus arteriosus. Nevertheless, most TOF 
babies are born without diagnosis and present the condition after birth. It is 
possible to strongly suspect TOF after comprehensive clinical assessment of 
the neonate. The typical clinical findings in the newborn with severe TOF are 
cyanosis and a systolic ejection murmur with a single second heart sound 
heard on auscultation(13). The diagnosis must be verified by transthoracic 
cross-sectional echocardiography with a complete description of the cardiac 
morphology performed in a systematic and sequential protocol. Other pre-
operative diagnostics, such as CMR or catheterization, are seldom needed 
before the primary procedure as ultrasound is sufficient to demonstrate all 
clinical attributes needed for the TOF diagnosis (8). 
 
2.2 SURGERY
2.2.1 SURGICAL HISTORY
The first steps towards the surgical treatment of TOF were taken at the Johns 
Hopkins Hospital in the USA in the early 1940s, where Dr Helen Taussig had 
observed that some children with cyanotic heart defect did better than others 
as long as their ductus arteriosus remained open but died shortly after the duct 
closed. Taussig approached cardiac surgeon Alfred Blalock, who created a left 
subclavian to left pulmonary artery anastomosis in an operation that took less 
Review of the literature 
22 
than 1.5 hours. After performing two other shunt operations, Blalock together 
with Taussing published this landmark series in 1945. Shunting was a 
palliative procedure and attempts to relieve the cyanosis but leaves the 
anatomical defect itself untouched. The repair of intracardiac malformation 
would need open heart surgery and it took several years before perfusion 
techniques were sufficiently developed to permit it.  
The first intracardiac procedure to correct a congenital heart defect was 
performed in 1953, when an atrial septal defect was closed through atriotomy 
by using hypothermia and inflow occlusion(21). Early attempts in performing 
open heart surgery on cardiopulmonary bypass were discouraging. However, 
Lillehei and his colleagues performed experiments with dogs using 
cross-circulation to permit open heart surgery with good outcomes. In 1954 
Lillehei used controlled cross-circulation on a boy of 11 years to correct his 
ventricular septal defect. The boy’s father was under anaesthesia and 
circulated and oxygenated his son’s blood (22). In the same year, using this 
bypass method, he performed the first complete repair on a Fallot patient. In 
his series using cross-circulation he operated on a total of 49 patients of whom 
22 survived(23). Despite this success, cross-circulation was abandoned 
because of the risks it posed to the donor. Nevertheless, Lillehei proved that 
by using extracorporeal circulation, open heart surgery was possible and the 
first successful mechanical cardiopulmonary bypass circuits were soon 
developed. Of special importance was J.W. Kirklin, who by a heart-lung 
machine set the standard for extracorporeal circulation and performed over 
500 operations of complete repair of TOF as a primary procedure or as 
secondary to shunt placement (24-27). Despite the success, several 
complications and technical issues were associated with early surgery of TOF. 
These included poor systemic perfusion, coronary air embolism, inadequate 
myocardial protection, and coronary artery injuries(28, 29).  
 
 
2.2.2 TOO EARLY OR TOO LATE?
During the early days of TOF surgery, complete repair was seldom performed 
on a patient under 3 to 5 years of age. In fact, an operating age of <5 years was 
associated with the highest early mortality; the best early survival was 
observed in age group of 5 to 15 years (30). However, in an early detailed report 
of infant patients undergoing repair, the authors observed increased mortality 
if the patient was followed until >2 years of age before complete repair (31). In 
this important study of Bonchek and Starr, the researchers noted that it was 
advantageous to perform repair at a younger age and to avoid waiting for the 
child to grow older. They also suggested that earlier timing would be beneficial 
in avoiding fibrosis and poor development of the RVOT. They observed that 
palliative shunting did not improve RVOT development and might even be 
detrimental and proposed that pulmonary annulus needs sufficient blood flow 
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for its development to prevent pulmonary atresia. In addition, this study was 
later recognized as an important description of the natural history of TOF 
pathophysiology(32). Later, several authors have presented that the repair of 
TOF can be achieved with good results even in neonates and infants(33-35). 
Accordingly, despite attempts during the three latest decades to move towards 
an earlier repair, controversies exist about the correct timing of the primary 
repair. Presently, it is widely a accepted policy that asymptomatic non ductus-
dependent infants should be operated between 6 to 12 months of age. In our 
tertiary unit in Helsinki University Hospital for Children and Adolescents, we 
attempt primary repair on most TOF patients before the age of 9 months.  
2.2.3 SURGICAL TECHNIQUES
Primary TOF surgery follows either a one-stage or two-stage protocol. 
One-stage refers to primary intra- and extracardiac repair, while two-stage 
refers to primary palliation with a shunt followed later by intracardiac repair. 
The two-stage repair procedure starts with the insertion of a Blalock-Taussig 
shunt, modified Blalock-Taussig shunt, or other shunt as the primary surgical 
palliation. The postoperative phase is associated with only partial relief of 
cyanosis. Palliation is later followed by a repair procedure. Currently, early 
primary repair is commonly preferred whenever the primary morphology is 
favourable.  
Surgical techniques have developed over decades for the intracardiac 
procedure. In the early days of surgery, the RV was vented from a large 
transverse or longitudinal ventriculotomy. Although transatrial-
transpulmonary approaches were introduced in the 1960s, they were widely 
brought to Fallot surgery in the early 1990s to avoid the detrimental 
ventriculotomy(16). In a traditional approach, the free wall of the RV is vented 
and both the ventricular septal defect and the obstructed right ventricular 
outflow tract are accessed through the same incision. In the transatrial 
approach, VSD is operated via atrial incision through the tricuspid valve and 
the RVOT obstruction is repaired from a smaller vent to the main pulmonary 
artery. The ventricular septal defect is closed with a patch and obstructive 
infundibular muscle fibres are resected. If necessary, the infundibulum or 
pulmonary annulus is enlarged with a patch to achieve better relief of 
obstruction(32, 36).  
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Figure 3 Transventricular and transatrial surgical techniques. In transventricular repair, 
both VSD and pulmonary stenosis are operated through a single incision. In 
transatrial repair, a VSD patch is inserted via atriotomy and pulmonary 
stenosis is operated through incision of the right ventricular outflow tract. 
Illustration by Emma Eskola. 
 
 
 
An important objective in developing the technique has been to preserve 
the pulmonary valve (37-39). This approach is currently used in almost all 
cases of total repair of Fallot irrespective of the primary condition and age of 
the patient (16, 39, 40). This is because transannular patching has consistently 
been reported as a significant risk factor for re-operation due to postoperative 
pulmonary regurgitation (PR) (41). Accordingly, a recent study with 16 years 
of follow-up showed that patients subjected to TAP exhibit a significantly 
higher risk of redo procedures but without difference in mortality(42). These 
observations have been contested by Bacha et al., who reported that the use of 
a TAP did not reduce late survival and did not increase the risk of a later re-
operation (43). Another recent investigation suggested that the use of TAP had 
no effect on late survival and had a lower incidence of RVOT re-stenosis, 
probably due to significantly greater relief of RVOT obstruction than in those 
whose pulmonary annulus was left untouched(44). However, a recent report 
contested this notion since it demonstrated that the use of TAP was not 
associated with higher risk of late death, risk of re-operation, or risk of PVR 
(45).  Hickey et al. stated that the annulus-sparing technique reduced the risk 
of RV dilation significantly in long term(46). 
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Figure 4 Transannular patch to relieve right ventricular outflow tract obstruction. 
Illustration by Emma Eskola. 
 
 
Simultaneous tricuspid valve repair has been under active research during the 
contemporary era of repair for cases where PR is associated with severe 
tricuspid valve regurgitation. The results are somewhat controversial and 
there is no current consensus (47-50). On one hand, PVR by itself seems to 
improve TR, thus making TV repair unnecessary. On the other hand, it is 
possible that in the presence of the most severe degrees of TR the pathological 
changes of TV are irreversible(51). 
When interpreting these somewhat controversial results, it is worth noting 
that the indications and timing of redo procedures differ between institutions, 
which has an impact on the incidence of operations. The choice of surgical 
technique is affected by the original morphology and patients with a severe 
defect are likely to undergo initial palliation or a more comprehensive surgery 
including a transannular procedure. Because of this, it is difficult to precisely 
distinguish whether the higher re-operation rate of TAP patients is because of 
surgical technique or the severity of the primary condition.  
Two-stage repair is associated with a myriad of untoward sequalae 
including the fact that it only partially relieves cyanosis, induces longer-lasting 
RV pressure loading, promotes distortion of the branch pulmonary arteries, 
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and is associated with death(43, 52). This approach is thus often avoided. With 
symptomatic infants some authors suggest that these patients should undergo 
two-stage repair(32) but other reports suggest that both approaches are 
reasonable choices as they have similar overall outcomes(53). The arguments 
for the two-stage strategy are the greater possibility to avoid TAP in the 
youngest patients and its influence on late outcome. The shunt can also 
facilitate growth of the pulmonary valve and pulmonary branches and small 
infants can avoid bypass and circulatory arrest procedures. Authors 
supporting early primary repair base their opinion on the normalization of 
growth and development of the heart and circulatory systems, and that by 
primary repair infants avoid long-lasting hypoxaemia and the adverse effects 
of hypercyanotic spells(43, 52). Finally, a long-lasting palliative stage with 
arterial shunt has also been recognized as a risk factor for LV dysfunction(9). 
Over decades, the surgical approach has changed from the two-stage repair 
using right ventriculotomy and TAP to a transatrial-transpulmonary 
technique as a primary intention(54). 
2.3 MODIFIED HISTORY AND FOLLOW-UP
2.3.1 EARLY AND LATE MORTALITY
There has been a drastic change in the operative mortality of Fallot surgery.  
Early mortality rates were as high as 14% in the early days of surgery. More 
recent studies have revealed a postoperative mortality of only 0% to 2%, and 
during the past 15 to 20 years the operative mortality rate has often been 
reported as close to zero (43, 55-58). 
Late survival of repaired TOF patients up to 20 postoperative years has 
been reported to be 80% to 86% after surgery performed in the earlier surgical 
era (1958-1989) (43, 55, 56). According to a late hazard model, approximately 
90% of patients with TOF corrected in the late 1980s and early 1990s are likely 
to survive into the fifth decade of life (45). Table 3 summarizes the results of 8 
studies that have reported early and late survival of TOF patients.  
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Table 3. Mortality in TOF patients according to the literature
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2.3.2 CAUSES BEHIND LATE MORBIDITY AND MORTALITY
Although the outcome of these patients has improved dramatically over the 
last decades, the long-term prognosis is still compromised by important 
chronic sequelae such as RV scarring, dysfunction, dilation, and arrhythmias, 
leading to higher morbidity and mortality than in their peers (59, 60). Surgical 
repair of RVOT obstruction often results in PR causing chronic volume loading 
and eventually RV dilatation and deterioration of function(61-65).  
2.3.2.1 Pulmonary valve regurgitation
In the long term, these patients may demonstrate progressive PR with RV 
dilation and dysfunction, which are known to be important determinants of 
adverse late outcomes (63, 65-67). In a study by Shimazaki et al., isolated 
pulmonary incompetence had a negative correlation with symptom-free 
survival. This patient cohort was remarkable in that almost no complications 
were reported for the first 30 years of life but after that rapidly progressing RV 
failure, sudden death, and exercise intolerance were observed(68). Impaired 
exercise tolerance, ventricular arrhythmia, and sudden death have all been 
reported as secondary complications of PR (62, 69, 70).   
2.3.2.2 Biventricular dysfunction
Although the RV has been the focus, the biventricular function and LV have 
been under active examination in recent years and emerging awareness has 
raised their importance in late outcomes of TOF. LV dysfunction has been 
reported as late sequelae in 20% of TOF patients. On the other hand, patients 
with normal RV ejection fraction (EF) were more likely to have normal LV 
function(71). Therefore, a strong correlation between RV and LV EFs has been 
documented in patients with repaired TOF(72). 
Late deterioration of RV and LV function has been an increasing concern 
during the current millennium(71, 73). A report by Cuypers stated an 
impairment of systolic RV function in 75% and systolic LV function in 50% of 
the patients with a median follow-up time of 36 years after repair(74). This 
concomitant dysfunction of the left heart appears to increase heart failure and 
mortality in these patients (63, 71, 72, 75). The reasons behind LV dysfunction 
in TOF patients have been under active examination. In one study, LV 
dysfunction was shown to be affected by preoperative hypoxaemia when 
hypoxaemia was evaluated by six parameters: preoperative systemic oxygen 
saturation, pre-operative haematocrit, LV/RV pressure ratios, hypercyanotic 
spells, one-stage or two-stage repair, and age at correction(76). Impaired 
ventricular-ventricular interaction is another possible contributor to LV 
dysfunction. In a study of Weyman et al., dilated RV was shown to cause 
displacement of interventricular septum and to change the shape of the 
septum and LV(77). Another study demonstrated altered LV rotation in 
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relation to RV volume load, suggesting the presence of ventricular-ventricular 
interactions(78). Tretter et al. divided these interactions into three categories: 
(i) mechanical coupling, which included shared aggregated cardiomyocytes, 
shared interventricular septum, shared pericardial space, and serial circuits; 
(ii) electromechanical coupling; and (iii) neurohormonal coupling by 
myocardial fibrogenesis. Similar mechanisms have been described by several 
other authors (79, 80). 
In the postoperative phase of repaired TOF, chronic pulmonary 
regurgitation causes profuse diastolic filling of the RV with dilation (81, 82). 
Accordingly, as many as 20% of late survivors of TOF develop a concurrent LV 
dysfunction, thus making this an important factor in the patient’s late 
outcome (71). PVR has been reported to improve LV EF(82).  
2.3.2.3 Rhythm disturbances and sudden death
Adult patients with TOF have a relatively high risk of tachyarrhythmias and 
prevalence increases with age, especially with atrial fibrillation and ventricular 
tachycardia(62, 83). In a study of Khairy et al., TOF patients with an average 
postoperative follow-up time of 32 years had a prevalence of sustained 
tachyarrhythmia of 29.9%. Ventricular tachyarrhythmia (mostly ventricular 
tachycardia) was present in 14.6% and atrial fibrillation in 7.4% of these 
patients. In particular, the prevalence of these two disturbances increased with 
age and markedly after 45 years. The authors reported that these arrhythmias 
were associated with LV rather than RV function and especially with LV 
diastolic dysfunction(84). A remarkably lower arrhythmia prevalence of 10% 
was reported in a Japanese multi-institutional study(85).  
TOF patients have a 0.15% to 0.2% risk of SCD(9, 86). Therefore, 
antiarrhythmic interventions are often needed(87). In a cohort of 408 
patients, freedom from arrhythmia intervention was 78.6% at 32 years after 
repair; implanted cardioverter-defibrillators were used in 10.4% and 
pacemaker in 7.9% of these patients(84). Indications for ICD were syncope, 
prolonged QRS, previous ventricular tachycardia, and severe systolic 
dysfunction of RV or LV. In a study of Bokma et al., PVR did not reduce the 
rate of SCD after a 5.3 years of follow-up(88) 
 
An overview of late complications with prevalence and annual risks is 
presented in table 4. 
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Table 4. Late complications of TOF (modified from Baumgartner et al. ((9))
 
 
2.3.3 POST-OPERATIVE FOLLOW-UP AND IMAGING
According to the European Society of Cardiology, all post-operative TOF 
patients should have a regular cardiological follow-up at a specialized clinic. 
This visit is recommended to be annual but can also be less frequent with 
patients at the milder end of the spectrum with stable haemodynamic 
condition. The evaluation should always look for the late complications 
presented in Table 4. Echocardiography should be performed at every visit and 
patients should be referred to CMR on a regular basis (9). 
1. Pulmonary regurgitation   
  • almost always developes, especially after TAP repair 
  • well tolerated for years 
  • when severe and chronic, leads to RV dilation and dysfunction 
  sometimes augmented by pulmonary artery stenoses 
2. Residual RVOTO 
• prevalence of ~40%   
  
• can occur at infundibulum, valvar level, at pulmonary trunk, 
distally (eveneven in distal parts of the pulmonary branch arteries) 
3. Residual VSD 
•prevalence of ~10%   
  
•due to rupture or failure of VSD closure, LV volume overload 
possible 
4. Aortic root dilation with 
aortic regurgitation 
•often progressive, prevalence of ~15%   
5. LV dysfunction 
•prevalence of ~20-50%   
  
•multiple causes, for example intraoperative hypoxemia, impaired 
ventricular-ventricular interaction and aortic regurgitation 
  •long-lasting palliative stage with arterial shunt increases risk 
6. Ventricular tachycardias 
•annual risk of 0.2%   
  •relates to haemodynamic problems  
  •risk increases as follow-up time gets longer 
7. Sudden cardiac death 
•annual risk of 0.15%   
  
•caused mostly by ventricular tachycardias or ventricular 
fibrillation 
  •causes approximately one third of all TOF late deaths. 
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2.3.3.1 Imaging modalities tetralogy of Fallot
An optimal imaging modality for late follow-up of TOF would allow a thorough 
assessment of all its morpohological and functional abnormalities. With an 
ideal tool, RV volume and pressure overload, valve regurgitations or stenosis, 
and RV and LV dysfunction could be adequately measured. Possible 
myocardial scarring, RV lesions, fibrosis, and associated anomalies (such as 
aortic root dilation) should also be assessed. Such a modality should be cost 
efficient, easily available, and should not expose to ionizing radiation(89).  
No single imaging modality fulfils these criteria and therefore at least four 
different tools are used for the late follow-up of TOF patients: (i) 
echocardiography, (ii) CMR, (iii) cardiac catheterization, and (iv) 
cardiovascular computed tomography. 
2.3.3.2 Echocardiography
Transthoracic echocardiography (TTE) is the first-line imaging examination 
in TOF both pre- and postoperatively. TTE is safe, causes no ionizing radiation, 
is easy to reproduce, and clinicans have a good level of expertise using it. RV 
and LV size and function, valvular stenosis, and regurgitation can be assessed 
by TTE. TTE yields haemodynamic estimates of RV and pulmonary 
pressure(89, 90). Advanced techniques, such as velocity vector imaging and 
speckle tracking imaging, enable early assessment of myocardial deformation 
and global and regional RV function. However, the use of these methods lack 
standardization for diagnostics (91). 
 
2.3.3.3 Cardiac magnetic resonance
Although pre-operative evaluation by echocardiography before the initial 
surgery is usually sufficient to demonstrate the surgical conditions, during the 
last two decades CMR has become the gold standard of postoperative imaging 
assessment of TOF patients(92). CMR allows reliable quantitative assessment 
of both RV and LV volumes, mass, and function(93-95). It also offers a 
possibility to study the pulmonary arterial branches and atrial function and 
volume. CMR is not dependent on ideal position of the heart in the thoracic 
cavity. As opposed to ultrasound, CMR also gives a full view to the right 
ventricular outflow tract. The volumetric assessment is performed manually 
and endocardial contours are drawn from both end systole and end diastole. 
EF is calculated from these measurements. Pulmonary and aortic 
regurgitation can be studied by using velocity mapping. PR can also be 
assessed by subtracting LV stroke volume and possible aortic regurgitation 
volume from RV stroke volume. CMR also allows precise evaluations of the 
aortic root and aortic insufficiency and permits quantifications of the 
distribution of flow to the left and right pulmonary artery.  
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2.3.3.4 CMR Feature Tracking
Strain and strain rate are techniques used in ultrasound and CMR and provide 
an on-site means to assess myocardial wall motion. Longitudinal strain 
measures the longitudinal shortening of the myocardium in the base-apex 
direction (negative value), circumferential strain measures the fibres 
shortening at transverse plane (negative value), and radial strain is used to 
describe myocardial motion towards the centre of the ventricular cavity 
(positive value). Strain rate is the rate of shortening of the length (1/s) and can 
be either systolic or diastolic (96, 97).  
By using ultrasound-based myocardial deformation imaging, LV 
early diastolic radial and circumferential strain rates (81) and LV systolic 
measures have been shown to be affected by RV dilation and pulmonary 
regurgitation despite preserved LF EF (98, 99). However, diastolic strain 
parameters have been difficult to assess using CMR tagging due to dephasing 
of magnetization. The non-rigid elastic registration-based FT used in this work 
has been shown to be reproducible and not be influenced by the level of 
training (100). CMR-FT provides an accurate and rapid assessment of both 
atrial and ventricular strain. CMR-FT is much less time consuming, does not 
require additional imaging sequences, and has better temporal resolution(101) 
when compared with myocardial tagging. 
2.3.3.5 Late gadolinium enhancement
Late gadolinium enhancement (LGE) is a diagnostic tool to detect scars and is 
based on the different distributions of gadolinium agent in different types of 
tissues. Contrast agent is distributed in the extracellular spaces but does not 
enter myocardial cells in physiological conditions. LGE occurs in pathological 
conditions either when the extracellular space of the tissue enlarges or the 
membranes of the myocardial cells are damaged, thus causing intracellular 
distribution of the gadolinium agent(102).  
The LGE technique has been used to assess ischaemic and non-ischaemic 
heart disease and has promoted the understanding of LV dysfunction and the 
pathophysiology of these diseases(103-106). The histologic base of LGE CMR 
imaging has been previously validated in studies of hypertrophic 
cardiomyopathy and cardiac amyloidosis (107, 108). Adverse clinical markers, 
for example ventricular dysfunction and arrhythmias, have been shown to 
correlate with LGE in an adult population of TOF(109).  
In clinical practice, LGE is assessed based on visual estimations and several 
grading protocols exist for diagnostics(109, 110). Some algorithms to assess 
LGE have also been developed and studied(111, 112). 
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2.4 RE-OPERATIONS AND INTERVENTIONS AFTER 
TOF REPAIR
2.4.1 PULMONARY VALVE REPLACEMENT
The post-operative phase of TOF patients is compromised by substantial 
morbidity. Due to pulmonary stenosis-relieving surgery, long-lasting PR leads 
to RV and LV dysfunction and often requires a re-operation to reconstruct the 
outflow tract of RV by replacing the pulmonary valve(62, 74, 113). The surgery 
is often performed by using valve homografts(93). PVR is known to reduce the 
size of the RV, stabilize QRS duration, and can reduce the risk of ventricular 
tachycardia(114, 115). LV function has also been reported to improve after PVR 
in paediatric and adolescent TOF patients(78, 82). Despite these results, the 
potential of RV to recover after PVR is possibly compromised in the adult 
population(116).  
All patients who suffer right heart failure, have overt symptoms of exercise 
intolerance, or have symptomatic ventricular tachycardia should be 
candidates for surgery. In addition, there are many borderline patients who do 
not fulfil these criteria but would still benefit from the surgery(9). 
Therrien et al. reported results from two series of PVR patients. In the first 
study, adult patients with a mean age of 34 years and grossly dilated RVs were 
shown to benefit from the operation at 2.4 years after the surgery. No 
significant PR was noted and the reported exercise capacity had improved. 
However, RV contractility and dimensions were not improved and tested 
exercise capacity was not improved(116). In another study with younger 
patients and lower degree of PR, both RVEDV and RVESV were decreased but 
RV EF remained unchanged at 21 months after PVR(116, 117). These authors 
suggested operative threshold values of RVEDV 170ml/m2 and RVESV 
85ml/m2 for PVR. Essentially similar thresholds have been reported by other 
authors(118, 119). According to the European Society of Cardiology, PVR 
should be performed if the patient has symptoms and PR or stenosis is severe 
(systolic RV pressure >60 mmHg and tricuspid regurgitation (TR) velocity of 
>3.5 m/s). If the patient has no symptoms, PVR is indicated if the tested 
exercise capacity is impaired, RV dilation or dysfunction is progressive, 
tricuspid valve regurgitation is at least moderate, or RVOTO is present with 
RV systolic pressure of >80 mmHg. Other indications are sustained atrial or 
ventricular tachycardia(9). The American Heart Association states that PVR 
should be considered if two of the following criteria are met: (i) RV end 
diastolic volume (RVEDV) ?160ml/m2 + RV end systolic volume (RVESV) 
?80ml/m2, (ii) mild or poor RV or LV dysfunction, (iii) RVEDV more than 
twice the LV end diastolic volume (LVEDV), (iv) RV systolic pressure 2/3 or 
greater than the systemic pressure, or (v) progressively impaired tested 
exercise capacity(120).  
Despite these thresholds, several questions related to the timing of PVR 
remain unanswered. For example, it is unclear how to treat an asymptomatic 
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patient with a threshold-size RV(121). Surgery itself is of low risk but potential 
complications still exist and the implanted valve may need a new replacement 
later in life (8, 122). In addition, subjective symptoms and exercise capacity 
are not shown to correlate, which makes decision-making even more 
difficult(8). There is no sufficient data about the functional benefits of surgery. 
Exercise performance is shown to improve after PVR but does not seem to 
correlate with ventricular remodelling in children and adults (123-125). 
Therefore, definitive data and guidelines for the timing of PVR are still absent. 
For some patients, PVR might never be necessary. Frigiola et al. suggested that 
patients surviving to 35 years of age with a normal exercise capacity could have 
had a definitive primary repair(126). 
Aortic valve replacement is to be considered with severe aortic 
regurgitation when symptoms or LV dysfunction are present. If residual VSD 
is diagnosed, the closure is indicated if patient shows LV volume overload or 
patient is undergoing PVR(9). 
2.4.2 CATHETER-BASED THERAPY
Transcatheter interventions are an important treatment option for 
postoperative TOF patients with RVOTO dysfunction. Transcatheter PVR 
(TPVR) is commonly done years after re-construction of RVOTO and is done 
with an adequate-sized homograft. This has been reported to be a feasible and 
beneficial technique especially when the patient has obstructive or mixed type 
of disease rather than severe RV dilation with abundant PR(127). The Melody 
valve (Medtronic, Inc., USA) is the only transcatheter pulmonary valve (TPV) 
approved for this indication by the FDA and in EU. Trials on other valves are 
in progress and only available in these settings(120). No criteria for RV size or 
function are established for TPVR and surgical PVR criteria are often used for 
guidance when assessing these patients. A lower risk of complications and 
faster postoperative recovery have often resulted in lower thresholds for this 
procedure. The American Heart Association recommends considering TPVR 
when at least moderate PR of RVOT conduit is present(128). In addition, 
recent reports support a more active approach to both PR and PS with lower 
than previous thresholds for intervention(51, 93, 127).  
2.5 GENETICS, PREGNANCY AND SOCIAL OUTCOME
2.5.1 GENETICS
The aetiology of TOF is multifactorial(16). It is most often considered to be 
sporadic even though the siblings of a TOF patient have an approximate 3% of 
recurrence risk if no other first-degree relatives with congenital heart defects 
exist(8). Knowledge about genetic abnormalities has increased vastly during 
the last two decades. Up to 25% of the TOF patients have been shown to have 
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chromosomal abnormalities, with trisomy 21 and microdeletion of the q11 
region of chromosome 22 (22q11 microdeletion) being the most common (16). 
In general, the prevalence of this disorder is 0.025%(129). Some authors 
suggest that the 22q11 microdeletion alone is present in up to 25% of TOF 
patients(17). The presence of genetic abnormalities has been shown to affect 
the outcome of TOF after surgical repair (130) and therefore it has been 
suggested that after primary diagnosis of TOF all patients should undertake 
an investigation with fluorescence in-situ hybridization to exclude 22q11 
microdeletion(17). This microdeletion is commonly diagnosed with a 
syndrome. The most severe type is DiGeorge syndrome with associated palatal 
abnormalities, learning disabilities, immune deficiencies, dysmorphic facial 
features and hypocalcaemia. A less severe 22q11 microdeletion-associated 
syndrome is velocardiofacial syndrome, where no immune deficiencies or 
hypocalcaemia typical of DiGeorge syndrome exist(131). Therefore, only 6% of 
TOF patients have a 22q11 microdeletion without any associated anomaly or 
syndrome(132). CATCH-22 is associated with several neuropsychiatric 
disturbances, such as attention deficit/hyperactivity disorder, anxiety, autism, 
depression, and bipolar disorder and psychotic disorders(129).  
 
2.5.2 PREGNANCY OF THE POST-OPERATIVE PATIENTS
Pregnancy is mostly well tolerated among women with TOF (133, 134). The 
risk of foetal loss and an increased proportion of congenital anomalies in the 
offspring are reported adverse foetal outcomes(135). Women with good 
haemodynamics, no symptoms, and only mildly dilated RV can expect a 
pregnancy outcome comparable to their healthy peers(133). Patients with 
RVOT obstruction, severe PR, and RV dysfunction can suffer from right heart 
failure and arrhythmias due to increased volume load during pregnancy (13, 
135). Therefore, when these patients are consulted before pregnancy, several 
authors suggest considering PVR before pregnancy(135, 136). Vaginal delivery 
is the recommended mode of delivery, cardiac function should be carefully 
monitored by a specialist, and labour should happen in a tertiary unit for high-
risk mothers(8, 136-138). According to the modified WHO classification of 
maternal cardiovascular risk, TOF is in class two with a small increase in 
maternal mortality and moderate increase in morbidity risk(139). The 
European Society of Cardiology recommends cardiological follow-up for these 
patients once every trimester(136).  
2.5.3 EDUCATION AND QUALITY OF LIFE
It has been reported that patients with cyanotic defects (study population of 
68% TOF, 24% TGA, 8% UVH) have a lower rate of university level of 
education when compared to the general population (3% vs. 7%). No statistical 
differences were found in rates of compulsory or vocational education rates 
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between this study population and healthy controls. When patients with 
significant mental retardation were excluded, no difference was found in 
occupational status of these patients(140). When personal health assessment 
was studied in adult population after TOF repair, excellent or good status was 
reported in 82% vs. 90% when compared to the normal population(141). The 
number of patients having offspring was slightly lower than expected (32% vs. 
39%, p<0.05). Marital status was similar to the general population(140).  
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3 OBJECTIVES
1. To establish population-based evaluation of the long-term results 
after TOF surgery in Finland starting from the first repair in 1962. 
2. To evaluate if LGE, suggestive of fibrosis, is present in paediatric 
TOF patients and if it relates to markers of adverse outcome. 
3. To study the mechanisms of how chronic PR affects RV and LV 
haemodynamics and myocardial function. 
4. To study whether myocardial function and ventricular 
haemodynamics differ after transannular patching in comparison to 
valve-sparing procedures.  
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4 METHODS
4.1 STUDY I: SURGERY OF TETRALOGY OF FALLOT IN 
FINLAND
4.1.1 SURGICAL TECHINIQUES TO REPAIR TOF
During the first decade of Finnish TOF surgery (1962-1969), the average age 
at repair was 9.4±3.0 years. During later decades we observed a gradual shift 
of operative ages towards early childhood and in the current millennium 
(2000-2007) repair was performed at the age of seven months. Today, it is 
widely accepted that the long-lasting palliative stage is detrimental to the heart 
and causes RV dilation and biventricular dysfunction. Accordingly, most 
centres prefer to repair TOF at approximately 6 months of age. In our 
institution, the surgery of the first decades was performed via ventriculotomy 
as the transatrial approach was introduced only in the 1980s and became a 
primary method of choice in the 1990s. Perioperative care and intensive care 
of TOF patients have also taken large leaps since the first days of surgery and 
partly explain the improved early and late outcome of these patients. 
4.1.2 PATIENT DATA
Patient data for the analysis was collected from the research database of 
paediatric cardiac surgery and additionally from hospital surgical logs, 
diagnosis cards, and computer files. The Research Registry of Paediatric 
Cardiac Surgery (Melba Group Helsinki) is a specially designed 
Filemaker-based database (Filemaker Pro version 11.0 v1, Filemaker Inc., CA, 
USA). Although paediatric cardiac surgery was centralized to Helsinki 
University Hospital in 1997, the registry contains all data of surgically 
operated paediatric cardiac patients in Finland and contains surgical data 
from the year 1953 to now. 
The study was closed on 24 of October 2012. To determine current patient 
status and dates of death and emigration, data were obtained from the Finnish 
Population Register Centre. For the study, all patients with a primary 
diagnosis of either TOF or DORV of TOF type found from the Research 
Registry of Paediatric Cardiac Surgery were included. Pulmonary atresia 
patients were excluded. This data query identified 705 patients who had 
undergone surgery for TOF between 1962 and 2007. The patients remaining 
in palliative stage (n = 75) and patients whose surgical operation took place 
after 15 years of age (n = 30) were excluded from the study, leaving 600 
patients for the final data analysis. The Finnish Population Register Centre 
registers all citizens with an unique social security number, which provided a 
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reliable method to identify and gather outcome data of our study population. 
Complete follow-up data were available for 595 patients (99%). Only 2 patients 
were lost to the follow-up and the follow-up ended prematurely in 3 patients 
due to emigration. In the survival analysis, the emigration day was considered 
as the last day of the follow-up for these patients. The characteristics of the 
study population is presented in Table 5. 
Table 5. Characteristics of study population
Total number of TOF surgical patients (n) 705 
Patients remaining in palliative stage (n) 75 
Patients operated after 15 years of age (n) 30 
Total number of enrolled patients (n) 600 
Operated between (years) 1960-2012 
Alive at closing day (n) 514 
Dead by closing day (n) 82 
Lost to follow-up (n) 4 
Age at correction   
 Primary intention (mean age; years) 3.4 ± 3.7 
 Previously palliated (mean age; years) 5.7 ± 4.7 
Transannular patch used (n) 191 
 
4.1.3 MORTALITY
Deaths within 30 days of surgery were considered early. The causes of late 
death were sought from death certificates obtained from Statistics Finland. 
For data analysis, deaths were divided by their main cause into congenital 
heart defect (CHD)-related and non-CHD-related deaths. Therefore, all 
patients with diseases with ICD-10 (International Classification of Diseases-
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10) diagnosis numbers Q20 to Q28 (in old cases ICD-9 numbers 745–747) 
were included in the CHD-related group. Patients with any other causes of 
death were classified as non-CHD related. We used a previously established 
classification of the cardiac causes of death to divide the CHD-related deaths 
into four categories: heart failure, sudden death, perioperative, and other 
cardiovascular death (142). SCD was defined as death (or irreversible 
deterioration before death) due to cardiovascular causes within 1 h of onset of 
symptoms or unwitnessed death during sleep(143). For perioperative deaths, 
all early (within 30 days) deaths due to patient’s first, second, or third re-
operation were included. The other cardiovascular death was a group that 
included all CHD-related deaths that could not be classified into the three 
groups mentioned above.  
4.1.4 RELIEF OF RVOT OBSTRUCTION 
From our research database of paediatric cardiac surgery, we were able to 
extract surgical data and to define the method of RVOT reconstruction in 551 
patients (92%) (Table 8). Despite the common congenital anomaly, the 
technique was always tailored for the specific patient according to the 
morphology observed on-site. The use of TAP is an effective method to relieve 
pulmonary stenosis but always results in permanent PR. The use of TAP was 
always an intraoperative decision. The pressure ratio between RV and LV was 
determined during the procedure. If the ratio was >0.7 and if the surgeon 
observed the residual stenosis at the annular level, the annulus could not be 
preserved and a TAP was inserted. 
 
4.2 STUDIES II-IV: THE HEARTS OF PAEDIATRIC AND 
ADOLESCENT TOF PATIENTS
4.2.1 PATIENT COHORT
4.2.1.1 Recruitment
Altogether 48 patients with TOF were included. The patients were referred to 
the study by a paediatric cardiologist due to echocardiographic findings 
suggesting significant PR and increased RV size. A total of 42 patients arrived 
from the Helsinki University Hospital district, serving a population base of 
1.7 million. Paediatric cardiologists from other hospitals referred 6 patients to 
the study according to the same criteria. For full benefit to the patients, their 
less comprehensive annual ambulatory visit was replaced with the study 
protocol and no additional visits were needed.  
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4.2.1.2 Surgical data
Patients were operated between 1990 to 2003. During the surgery, 
cardiopulmonary bypass with aortic crossclamp was used. Cold blood 
cardioplegia was used for myocardial protection. During the first 7 years, 20 
patients were repaired and 7 (35%) received TAP. During the last 7 years, 28 
of patients were repaired and 20 (71%) received TAP. Initially, palliation was 
performed altogether on 8 patients over both 7-year surgery periods.  
4.2.2 HEALTHY CONTROLS
Healthy volunteers were recruited from local schools, girl guides, boy scouts, 
and family members of the healthcare staff. Forty-four healthy age- and 
gender-matched paediatric and adolescent volunteers were recruited for the 
study. The following admission criteria were used: (i) no medical history of 
any cardiovascular disease and (ii) no other pre-existing condition that would 
affect the cardiovascular system.  
4.2.3 STUDY PROTOCOL
A paediatric cardiologist performed a morphologic ultrasound, clinical 
examination, and ECG to exclude possible latent cardiac problems. CMR 
imaging was performed on all patients and healthy controls. Blood samples 
from a peripheral vein were drawn from all subjects.   
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Table 6. Magnetic resonance imaging protocols in the study. *LGE grading was 
performed according to our newly developed grading method (144).
4.2.4 CMR IMAGING TECHNIQUES
The CMR study was performed using a 1.5T Philips Achieva System engine. 
Volumetric analysis was based on manual planimetration. When using CMR 
to study PR, it is possible to use either the difference of the ventricular 
stroke volumes (ml/m2) or mapping of phase-contrast of the 
main pulmonary artery flow (%). The use of stroke volume difference has been 
reported to better correlate with ventricular volumes(145, 146) and was 
preferred in our studies.  
LGE grading was performed by visually assessing the images and a 
previously published RV LGE grading protocol that had seven RV segments, 
including the target locations of surgical repair, which served as a basis for our 
grading method (109).  
For the atrial volume measurements, transaxial cine images were manually 
planimetered according to a previously described method(147). The cyclic 
volume change was calculated by using atrial volumetric measurements by 
substracting minimal atrial volume from maximum. Conduit volume refers to 
diastolic blood flow to the chambers while the atrial pump remains passive. 
This was assessed by subtracting the cyclic volume change from the LV stroke 
 43 
volume. The combined preload volumes from the atria for each ventricle were 
calculated by adding the cyclic volume change to conduit volume. 
CMR strain analysis was performed using Segment software® and FT was 
performed retrospectively by manually drawing the first cine image and the 
other sequences automatically by software.  
We measured time-strain curves covering the entire cine image sequences. 
Peak systolic strain (%), peak systolic strain rate (%/s), and peak diastolic 
strain rate (%/s) were calculated from the curves. TOF patients have 
ventricular dyssynchrony and delayed RV contraction when compared with 
healthy controls(148, 149). Therefore it is difficult to compare the strain curve 
of a TOF patient and a healthy controls. To allow visual comparison of the 
strain curves we used heart rate correction for the RR-interval. We linearely 
corrected the RR-interval of the strain curves to match a heart rate of 68 
(mean of the healthy controls). The correction is similar to Bazett’s formula 
for heart rate corrected QT interval. Heart rate determines the duration of the 
RR-interval, and with no correction no temporal comparison between the 
strain curves would have been possible. CMR imaging methods, techniques, 
and protocols are summarized in Table 6. 
 
4.2.5 CHARACTERISTICS OF THE STUDY POPULATION (STUDIES II-
IV)
 
Our study patients were children and adolescents with a mean age of 13.1±3.3 
years. Primary palliation prior to corrective surgery was performed on 16 
(40%) patients. TAP was inserted in 24 (53%) patients. A re-operation after 
primary correction was needed for 6 patients (15%) during the follow-up time 
of the study (2007-2014).  
The CMR was not comprehensive for all patients or controls because of 
insufficient image quality due to technical reasons or patient anxiety. 
Depending on the different CMR methods used in studies II to IV, some but 
different patients were rejected in each study because of poor image quality.  
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Table 7. Characteristics of the study population (studies II-IV)
4.3 STATISTICAL ANALYSIS
Statistical analysis was performed using both IBM SPSS Statistics 19 and 24 
(IBM Corp., Armonk, NY, USA) and GraphPad Prism 5.0a (GraphPad 
Software, Inc. San Diego, California, USA). All results are reported as 
mean±SD. Comparisons of continuous data between the groups were 
performed using an unpaired t test. Correlations were calculated by using 
Pearson correlation coefficient. A two-tailed P-value of less than 0.05 was 
considered statistically significant. Inter-observer variability was tested by 
using Spearman’s test and the Bland-Altman method. Intra-observer 
variability between strain measurements was evaluated by using intraclass 
correlation coefficient (ICC). 
We assessed the time-related mortality with survival analysis and used the life-
table method. For survival analysis, we calculated one overall survival for all 
patients. We performed a separated analysis for patients operated on during 
the last four eras (1970–1979, 1980–1989, 1990–1999, and 2000–2007). The 
survival rates between patients with and without primary palliation were 
compared and the survival of patients with and without TAP was analysed. To 
evaluate the effects of different surgical methods on the need for re-operation, 
the event-free survival of the patients was also studied. For this analysis, death 
and re-operation were considered as events. Survival analyses of the study are 
presented as Kaplan-Meier plots.  
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The Wilcoxon (Gehan) paired test was used to compare survival with 
different groups. For the analysis of the proportion of TAP operations or re-
operations after palliation, the χ2 test was used.  
4.4 ETHICAL APPROVAL AND CONSENTS
The Ethics Committee of the Children’s Hospital of the Helsinki University 
Central Hospital approved the study. Written informed consent was obtained 
from all the participants or their parents. 
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5 RESULTS
5.1 SURGERY OF TETRALOGY OF FALLOT IN FINLAND
(STUDY I)
5.1.1 EARLY AND LATE RESULTS AND CAUSES OF DEATH
5.1.1.1 Patients
We studied a 45-year period of surgery closing at the end of 2007, which 
included the first repair of TOF in Finland in 1962. During that time, repair 
(or total correction) was performed in 600 patients who were younger than 15 
years at the time of the surgery. The closing day of the follow-up was the end 
of 2012. The study consisted of 10 517 patient-years and the mean follow-up 
time was 23±12.1 years (range 0-49.9 years). There was a 60% male 
predominance in our study population. On the closing day of the study, the 
mean age of the patients was 25±14.5 years (range 0.23-61 years). The follow-
up rate was as high as 99.1%. 
5.1.1.2 Early mortality
In our study population we observed an 85.5% survival rate where 514 
patients were alive and lived in Finland. Eighty-two patients succumbed, 
making the overall mortality 13.7%. Of these 82 deaths, a total of 40 (6.7%) 
were early (≤30 days after corrective surgery) and 42 (7.0%) were late (>30 
days after corrective surgery). The early mortality of the last two decades was 
only 1.5% and we did not observe early deaths after the year 2000.  
5.1.1.3 Need for re-operation
According to our study, a total of 121 (20.1%) patients needed re-operation 
during the 23-year follow-up period. The most common intervention was PVR. 
There were 7 early deaths in this group, which in this study were reported as 
late deaths after total correction.   
5.1.1.4 Late survival
We observed a late survival rate of 86% in our study population. Survival of 
the first 5 years was 91%, 10 years 90%, 20 years 88%, and 40 years 83%. The 
late survival of our patients is presented in Figure 5. 
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Figure 5 Overall survival of TOF patients (n=600). The numbers above the curves show 
the number of living patients 25 and 43 years after corrective operation. Early 
mortality is included. Modified from Ylitalo et al., Eur J Cardiothorac Surg 2015, 
with permission from Oxford University Press.
 
 
Excluding the first postoperative follow-up year after repair, our patients could 
expect an almost 100% survival rate during childhood as the first increment of 
mortality was seen in late adolescence. Thereafter, the attrition rate 
progressed initially slowly but escalated after 40 years of life (Figure 5). 
5.1.1.5 Causes of late mortality
We identified the causes of death in all 82 patients. When examined in detail, 
we observed 66 deaths related to TOF and 11 deaths were unrelated to the 
heart. The exact causes of deaths are reported in Table 8. 
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Table 8. Causes of death of the Finnish TOF population
 
Results   n  % 
Alive   513 85.5 
Death   82 13.7 
  Early mortality 40   
  Late mortality 42   
Unknown   5 0.8 
  Emigrated 3   
  Lost to follow-up 2   
Late mortality       
  Early mortality in reoperations 7 1.2 
  Late cardiac death 19 3.2 
  Sudden death 13   
  Heart failure 5   
  Cardiovascular death 1   
  Late non-cardiac death 11 1.8 
  Accident 2   
  Alcohol poisoning 2   
  Cancer 2   
  Suicide 2   
  Hydrocephalus 1   
  Epileptic attack 1   
  Pneumonia 1   
  Late death, unknown reason 5 0.8 
 
 
 
In our present patient cohort, SCD had an incidence of 0.12% per patient-year 
and was the most common late cause of mortality related to cardiac reasons.  
The two other late causes of cardiac deaths were heart failure and 
cardiovascular death, which included all CHD-related deaths that could not be 
classified into SCD or heart failure. We reported a 1.8% rate of mortality due 
to non-cardiac causes, including diverse reasons such as accidents, cancer, and 
suicide (Table 8). 
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5.1.2 THE METHOD OF RVOT RECONSTRUCTION
5.1.2.1 Transannular patch as a surgical technique
TAP was inserted in 191 (32%) of the repairs performed, pulmonary valve 
annulus was preserved in 60%, and the method could not be defined in 8% of 
the patients. Surgical data including the operative ages of different surgical 
eras are presented in Table 9. 
 
Table 9. Surgical data of study population
Primary procedures n % 
      
Primary correction 451 75.2 
Primary palliation 149 24.8 
Transannular patch (TAP) used 190 31.7 
TAP not used 361 60.2 
Use of TAP unknown 49 8.2 
  
  
Re-operations ( ≥1 ) 
All patients 122 20.3 
Patients primary corrected 67 14.9 
Patients primary palliated 55 36.9 
Patients with TAP 57 30.0 
Patients with no TAP 58 16.1 
 
 
Operative ages (years) Mean Median Range 
    
Age at correction 3.9±4.1 2.0 0.02-15.0 
1962-1969 9.4±3.0 10.8 1.7-12.7 
1970-1979 8.0±4.0 7.9 0.4-15.0 
1980-1989 3.4±3.1 2.2 0.1-14.5 
1990-1999 1.8±2.1 1.3 0.1-13.1 
2000-2007 0.7±0.8 0.6 0.2-6.6 
Age at correction (primary 
intention) 
3.4 ± 3.7 1.7 0.02-15.0 
Age at correction (previously 
palliated) 
5.7 ± 4.7  4.3 0.2-14.8 
Age at primary palliation 1.4 ± 2.0 0.6 0.0-9.3 
Age at first re-operation 14.1 ± 12.6 9.5 0.4-54.9 
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5.1.2.2 Effects of TAP on early and late survival
We did not observe an increase in all-cause mortality in patients with TAP 
when compared to those whose pulmonary valve annulus was preserved 
(12.1% vs. 12.7%). The survival of TAP and non-TAP patients is presented in 
Figure 6. 
 
Figure 6 Survival after TOF repair with or without transannular patch (=TAP or no TAP). 
Numbers above the curves show the number of living patients 25 and 43 years 
after corrective operation. Early mortality is included. Modified from Ylitalo et 
al., Eur J Cardiothorac Surg 2015, with permission from Oxford University 
Press.
 
5.1.2.3 TAP decreases event-free survival
We studied the significance of TAP on the time-related risk of re-operation 
after excluding early mortality. Both re-operation and death were considered 
as events in this analysis (Figure 7). We observed a significantly inferior 
event-free survival in patients if reconstruction of the RV outflow tract was 
performed by using TAP.  
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Figure 7 Effect of TAP on event-free survival. Modified from Ylitalo et al., Eur J 
Cardiothorac Surg 2015, with permission from Oxford University Press.
5.1.3 PRIMARY CORRECTION VS. PRIMARY PALLIATION
5.1.3.1 Survival of primary palliated patients
In our study population, primary palliation was performed on 149 (25%) 
patients. The proportion of primary palliations over five consecutive decades 
was 71%, 21%, 15%, 25%, and 15%.  
We observed a significantly inferior late survival of these patients when 
compared to those whose primary operation was repair (20.8% vs. 12.8%, 
P=0.007, respectively; Figure 8). The surgeon was less often able to preserve 
the pulmonary valve annulus during the correction if palliation had taken 
place previously (41% vs. 29%, P=0.001). These patients more likely had a 
difficult original morphology or more severe pulmonary obstruction and thus 
needed an early palliation; therefore pulmonary valve preservation was not 
possible at repair. 
 
 
 
Results 
52 
Figure 8 Survival of patients with or without primary palliation. Numbers above the 
curves show the number of living patients 25 and 43 years after corrective 
operation. Early mortality is included. Modified from Ylitalo et al., Eur J 
Cardiothorac Surg 2015, with permission from Oxford University Press.
5.1.3.2 Primary palliation and re-operations
We also observed a higher rate of re-operations in this study group of patients 
with primary palliation (36.9% vs. 14.9%, P<0.001). The data on the freedom 
from re-operation or death after primary palliation and primary correction are 
shown in Figure 9. 
 
 
 
 
 
 
 
 
 
 
 
 
 53 
Figure 9 Event-free survival (event= re-operation or death) of TOF patients with or 
without primary palliation. Numbers above the curves show the number of 
living patients 25 and 43 years after corrective surgery. Early mortality is 
excluded. Modified from Ylitalo et al., Eur J Cardiothorac Surg 2015, with 
permission from Oxford University Press.
 
 
5.2 CARDIOVASCULAR MAGNETIC RESONANCE 
IMAGING OF TOF PATIENTS WITH PULMONARY 
REGURGITATION (STUDIES II-IV)
Patient history was assessed from patient charts and surgical logs. No time-
related trends in perfusion times or aortic closure times were observed. All 
patients had right bundle branch block in their rest ECG recording.   
5.2.1 GRADING OF PR AND FACTORS DETERMINING ITS
DEGREE
PR was present in all study patients. The use of TAP had a clear effect on PR, 
as patients with TAP had mostly severe PR (>30ml/m2), n=11) whereas 
patients with preserved pulmonary valve annulus had mostly non-severe PR 
(<30ml/m2), n=23, only 2 patients exceeding the limit). The mean PR of TAP 
patients was 30.8 ml/m2±10.2 (range 16.7-59.4) and the mean PR for non-TAP 
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patients was 9.8 ml/m2±10.3 (range 0-31.8). We only observed negligible PR 
in control subjects.  
5.2.1 RIGHT VENTRICULAR VOLUMES AND FUNCTION
 
In study III we observed elevated RV volumes (both diastolic and systolic) 
when compared to control subjects (P<0.0001). PR also had an effect on RV 
stroke volume but had no effect on RVEF (table 10). Patients with PR 
<30 ml/m2 had comparable RV stroke volume as healthy subjects. RV sizes 
and functions are described in detail in Table 10.  
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Table 10. Right ventricular volumes, function, and pulmonary regurgitation of patients with 
severe (>30ml/m2) and non-severe (≤30ml/m2) pulmonary regurgitation and 
healthy controls.
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5.2.2 LEFT VENTRICULAR PRELOADING, VOLUMES, AND 
FUNCTION
In study III we observed smaller LV end diastolic and stroke volumes in rTOF 
resulting from abnormal LV filling.  The left atrial maximum volume, cyclic 
volume change, and conduit volume were smaller when compared to healthy 
controls. When PR >30 ml/m2, patients presented significantly diminished LV 
end diastolic volume, LV stroke volume, and LV EF when compared to the 
control subjects. Patients whose PR was <30 ml/m2 had LV volumes and EF 
similar to healthy subjects (Table 11). 
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Table 11. Left ventricular preloads, volumes, function, and pulmonary regurgitation of 
patients with severe (>30ml/m2) and non-severe (≤30ml/m2) pulmonary 
regurgitation and healthy controls.
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5.2.3 MYOCARDIAL CINETICS  
5.2.3.1 CMR Feature Tracking 
CMR-FT is a novel method to assess wall motions and disturbances of both the 
RV and LV. In study IV, we chose to assess the myocardial function with CMR-
FT, where the image quality is maintained throughout the cardiac cycle. Our 
intra-observer variability analysis agreed with this result. The analysis was 
performed by manually drawing the wall contours in the first cine image at the 
end of diastole (Figure 10).  
 
Figure 10 (i) Mid-ventricular short-axis view of the LV and RV in a patient with TOF at 
end diastole. LV epicardial and endocardial borders as well as RV endocardial 
borders have been manually drawn in the image.  
(ii) The resulting strain curves for LV circumferential (dashed line) and radial strain 
(solid line). Different markers along the curves (. and *) correspond to different time 
points in the cine image sequence (i.e., there are 30 temporal phases in the image 
sequence).  
 
 
5.2.3.2 Circumferential and longitudinal strains 
When rTOF and controls were compared, we observed an increase in all RV 
circumferential measures (strain, systolic strain rate, and diastolic strain rate) 
of the patient group (Table 12). 
RV peak longitudinal strain was significantly increased in rTOF patients 
with PR >30 ml/m2 when compared to those with PR <30 ml/m2 (-
22.5%±2.7% vs -19.7%±3.5%, P=0.018) and controls (19.4±3.2%, P=0.007). 
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No difference in RV peak longitudinal strain was present between rTOF 
patients with PR <30 ml/m2 and controls. In rTOF patients, PR had a negative 
correlation with RV systolic longitudinal strain rate (R=-0.37, P=0.030) and a 
positive correlation with RV diastolic longitudinal strain rate (R=0.39, 
P=0.021).  Thus, patients with florid PR had on average higher RV longitudinal 
peak strain in the rTOF population (Table 11). This was considered as a 
possible but appropriate compensation of the RV function.  
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Table 12. RV circumferential and longitudinal strain data of TOF patients (TOF), healthy
controls (Healthy), and TOF patients in two groups divided according to the 
severity of pulmonary regurgitation (TOF PR <30 ml/m2 and TOF PR >30
ml/m2).
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LV longitudinal diastolic strain rate was the only LV strain parameter to differ 
between rTOF patients and controls (65.9 [%/s±19.1 vs. 81.9±31.1) 
5.2.3.3 Segmental strain analysis
By grouping the circumferential strain measurements to apical, mid, and basal 
regions, we noticed that the peak strain values increased from base to apex in 
all study groups. Strain in our normal controls was similar at basal and mid-
level and highest (on average 2.5% higher) in the apical plane as described 
previously (150). RV circumferential strain in different short-axis planes was 
measured and peak strain was significantly increased in all planes in the entire 
TOF population. The increase was highest at the mid-ventricular and apical 
levels (P<0.0001). There were no differences between the two TOF subgroups 
(Table 12 and Figure 11). 
 
Table 13. Segmental right ventricular circumferential strain of healthy controls, rTOF 
patients, and rTOF patients in two groups according to the severity of pulmonary 
regurgitation (TOF PR <30 ml/m2 and TOF PR >30 ml/m2).
Right ventricle plane         
  Healthy (N=44)   TOF (N=40)   P-value   
Base   -11.2 ± 2.9   -13.1 ± 3.8   0.01*   
Mid   -10.7 ± 3.4   -16.8 ± 4.2   < 0.0001*   
Apex   -13.5 ± 4.2   -20.7 ± 5.0   < 0.0001*   
  TOF PR < 30 (N=29)   TOF PR > 30 (N=11)   P-value   
Base   -12.8 ± 4.0   -13.9 ± 3.1   0.341   
Mid   -16.6 ± 4.0   -17.3 ± 5.0   0.636   
Apex   -20.8 ± 4.7   -20.4 ± 6.0   0.876   
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Figure 11 Mean RV circumferential strain curves in basal, mid-ventricular, and apical 
planes with heart rate corrected to 68 (mean HR of healthy controls) in each 
group. LV=left ventricle, RV=right ventricle, PR=pulmonary regurgitation 
(ml/m2).  
  
 
 
In comparison with healthy controls, the timing of both circumferential and 
longitudinal RV peak systolic strain was delayed. This was similar within the 
two patient groups. LV longitudinal strain in diastole returned to baseline 
faster in patients with TOF than in healthy subjects (Figure 12).  
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Figure 12 Mean strain curves with heart rate corrected to 68 (mean HR of healthy 
controls) in each group. LV=left ventricle, RV=right ventricle, PR=pulmonary 
regurgitation 
 
 
 
 
 
5.2.4 MYOCARDIAL FIBROSIS 
5.2.4.1 Late gadolinium enhancement imaging technique 
LGE detected with MRI after this contrast agent is recognized as a marker of 
fibrotic scars or otherwise abnormal myocardium. In study II, LGE was used 
to study myocardial fibrosis. Typical LGE findings are shown in Figure 13. 
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Figure 13 Late gadolinium enhancements finding (white arrows) in the anterior wall of the 
right ventricle. Modified from Ylitalo et al., Int J Cardiol Heart Vessel 2014, with 
permission from Cambridge University Press.
5.2.4.2 LGE grading protocol
A previously published RV LGE grading protocol that had seven RV segments 
(including the target locations of surgical repair) served as a basis for our 
grading method (109). In study II, a new grading protocol was developed as 2 
surgically scarred segments (VSD patch region and the anterior wall of RVOT) 
of the RV were omitted to allow grading RV LGE outside the surgically 
intercepted myocardium.  
Therefore, the following five segments were elected for the LGE grading: 
anterior wall of RV, inferior wall of RV, RV surface of septum, trabecular 
bands, and RV insertion points. Visual assessment of the late enhancement 
images was used and each segment was studied by grading the enhanced 
myocardium according to the protocol (Figure 14). 
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Figure 14 Five-step segmental late gadolinium enhancement grading protocol: in the first 
three segments measuring right ventricular (RV) free wall and the 
interventricular septum, the scoring was performed as follows: 0 = no 
enhancements, 1 point <2 cm, 2 points = 2-3 cm, and 3 points > 3 cm in 
length. RV trabeculations were scored as 0 points = no enhancement, 1 point 
= enhancement of one trabeculation, 2 points = enhancement of 2-4
trabeculations, and 3 points = enhancement of more than 4 trabeculations. 
RV-LV insertion points were scored either 0 points or 1 point for absence or 
presence of enhancements. Modified from Ylitalo et al., Int J Cardiol Heart
Vessel 2014, with permission from Cambridge University Press.
 
5.2.4.3 LGE in rTOF patients
Using our application of the grading method, LGE suggested fibrosis caused 
by reasons other than direct surgical manipulation. This was observed in 39 of 
40 patients. LGE was not observed in any of the control subjects. LGE was 
frequently found in all 5 remote segments of RV and most commonly in the 
anterior wall in 33/40 patients (83%) followed by RV insertion points in 27/40 
patients (68%). In the remaining three segments, the inferior wall was 
enhanced in 16/40 patients (40%), RV surface of septum in 15/40 patients 
(38%), and trabecular bands in 9/40 patients (23%). 
RV EDV had a significant positive correlation with LGE score (Figure 15A). 
A PR fraction of 30% was used as a cut-off for severe PR. A higher LGE was 
observed in those with severe PR (n=40, P=0.008, Figure 15B). A significant 
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positive correlation between LGE score and post-operative follow-up time 
(n=40, r=0.44, P= 0.0045) is shown in Figure 15C. 
 
Figure 15 A: Correlation between right ventricular end diastolic volume (RV EDV) and 
remote late gadolinium enhancement (LGE) score (n=40, r= 0.44, P=0.0045). 
B: Remote late gadolinium enhancement (LGE) score of patients with severe 
pulmonary regurgitation (PR) (≥30%) when compared with patients with PR <30%
(n=40, P=0.008). 
C: Correlation between post-operative follow-up time and remote LGE score (n=25,
r=0.53, P=0.006). Only patients with ≥20% PR were included in this analysis.
Modified from Ylitalo et al., Int J Cardiol Heart Vessel 2014, with permission from 
Cambridge University Press.
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6 DISCUSSION
This thesis presents a population-based evaluation of early and late outcomes, 
modes of surgery, and causes of death after TOF surgery in Finland since the 
first primary repair in 1962. We studied the clinical state and cardiac function 
of paediatric and adolescent TOF patients and their healthy peers. We used 
novel methods for this purpose and present new findings for possible clinical 
use. We also propose new mechanisms behind rTOF cardiac dysfunction. 
6.1 SURGERY OF TETRALOGY OF FALLOT IN FINLAND
(STUDY I)
6.1.1 EARLY AND LATE RESULTS AND CAUSES OF DEATH
6.1.1.1 Early mortality
In this study population we reported an 85.5% survival rate. There was a total 
number of 82 deaths; 40 (6.7%) were early (≤30 days after corrective surgery). 
During the last two decades early mortality was only 1.5% and we did not 
observe early deaths after the year 2000.  
In a study of Hickey et al., 1181 patients operated between 1960 to 1998 had 
an early mortality of 10%(45). Cuypers et. al observed a 16% early mortality in 
patients operated between 1968 to 1980(74). Studies on early results in 
patients operated after 1990 report significantly lower early mortality rates 
(0-2%)(57, 58). Our present findings corroborate well with another 
Scandinavian study(42) where the authors reported a 16-year follow-up with 
an early mortality rate of 5.7%. These authors presented an early mortality rate 
of 2.1% in the 1990s and 0.6% in the 2000s in a Norwegian population. 
Accordingly, it seems that during the last two to three decades the early 
mortality has been getting close to or has even reached zero in several 
institutions. This is most likely due to the improved perioperative care, 
advanced surgical techniques, and modern intensive care.  
 
6.1.1.2 Need for re-operation
We observed a re-operation rate of 20.1% (n=121) during the 23-year follow-
up period of our study. PVR was the most common type of re-intervention. 
Lujiten et al. reported a PVR rate of 11.5% after a 15-year follow-up. A study 
by Park et al. stated a re-operation frequency of 31.7% with a mean follow-up 
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of 12.5 years(151, 152). In a study of Hickey et al., the late risk for re-operation 
was as high as 50% 30 years after repair and was independent of surgical 
era(45).  Our results are comparable to these results but show lower rates of 
re-operation. As opposed to overall, and especially with early survival, the 
need for re-operations in our study remained constant over the decades and 
compare with the aforementioned study (45).  
6.1.1.3 Late survival
We observed a late survival rate of 86% in the present patient series. Our 
results are consistent with a US study from 2009, where an overall survival 
rate of 82% in a cohort study of 1181 patients was reported. Also in this study 
population, the survival was higher (94%) in patients treated in the later years 
of TOF surgery (after 1985); early mortality was lower (2%) in these 
patients(45). Our present findings are consistent with a study of Linberg et al., 
where the authors reported a 16-year follow-up and observed an overall 
survival of 89% in a population of 570 patients who underwent repair between 
1952 to 2008(42). Similar to our results are those from Cuypers et al., who 
reported a 40-year late survival rate of 86%. A study by Kirsch et al. on 277 
patients operated on after 1995 reported a 10-year survival rate of 100%. 
Alexiou et al. reported a 20-year survival rate of 98% for 89 patients operated 
on between 1974 to 2000(58, 153). Accordingly, it seems that the late results 
are improving decade after decade. Nevertheless, we reported an increase in 
mortality after 40 years and therefore the late results of the 1990s and the 
current millennium should be later re-assessed. 
6.1.1.4 Causes of late mortality
In our present patient cohort, we observed a SCD incidence of 0.12% per 
patient-year. SCD was the most common late cause of mortality related to 
cardiac reasons. Our observation of a relatively high risk of SCD is similar to 
what has consistently been reported in the literature. Silka et al. reported an 
annual incidence o.15%(154); the overall risk of SCD has varied from 2.0% to 
8.3%(59, 62, 155). In an Australian autopsy study of cardiac deaths in TOF, 
overall 23 decedents were analysed and 17 (74%) were classified as SCD, 4 
(17%) non-cardiac, and 9% unspecified. The mean age of death in this study 
was 36 years. 
The other two late causes of cardiac deaths in the present series were heart 
failure and cardiovascular death, which included all CHD-related deaths that 
could not be classified into SCD or heart failure. We reported a 1.8% rate of 
mortality due to non-cardiac causes with a diverse range of reasons, for 
example accidents, cancer, and suicide (Table 2). 
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6.1.2 THE METHOD OF RVOT RECONSTRUCTION
 
We did not observe an increase in all-cause mortality in patients with TAP 
when compared to those whose pulmonary valve annulus was preserved. A 
Norwegian study with 16 years of follow-up similarly showed that TAP had no 
effect on mortality (42). Other authors have stated that late survival bears no 
relation to the use of TAP and have observed a better relief of RV obstruction 
in TAP patients. The authors also suggested the more severe morphology of 
these patients as a reason for this observation when compared to those with 
preserved pulmonary valve annulus(44). Hickey et al. made similar 
observations, as they did not demonstrate an association between the use of 
TAP and risk of late death(45). 
We observed a significantly inferior event-free survival in patients if 
reconstruction of the RV outflow tract was performed by using TAP. The use 
of TAP has been reported as a significant risk factor for re-operation since the 
severe postoperative PR causes RV dilation, deterioration of RV function, and 
impairment of exercise function. The risk is especially high when the condition 
is accompanied by remarkable distal vessel stenosis(41). Slightly different 
results regarding the need of TAP were reported from a large study of 1181 
patients, where both the risk of re-operation or need for PVR were not 
increased(45). The operative age in this study of general rTOF population was 
much higher (7.6 vs. 3.9 years), prior palliation was performed more often 
(53% vs. 25%), and the study was closed earlier (1998 vs. 2007) when 
compared with our study.  
 
6.1.3 PRIMARY CORRECTION VS. PRIMARY PALLIATION
 
Supporters of primary palliation point out that primary correction often needs 
aggressive RVOT resections and can possibly carry a higher risk of neonatal 
adverse effects and have longer postoperative recovery times(156). However, 
according to contemporary reports, the initial correction has no association 
with higher rates of early mortality when compared to a two-stage repair 
approach (157, 158). Higher rates of early mortality and need for re-operations 
have also been reported(45). Our population-based study with over 20 years 
of mean follow-up time revealed clearly higher mortality rates in palliated 
patients when compared with primary correction. The event-free survival was 
also inferior in this patient group. Accordingly, the initial morphology of the 
palliated patients was likely more complex and these patients were more often 
infants when a Blalock-Taussig type shunt was placed. During the current 
millennium, our approach of choice has been primary repair also in the 
youngest patients from a weight of 4 kg upwards.  
 71 
6.2 CARDIOVASCULAR MAGNETIC RESONANCE 
IMAGING OF TOF PATIENTS WITH PULMONARY 
REGURGITATION (STUDIES II-IV)
6.2.1 RIGHT VENTRICULAR VOLUMES AND FUNCTION
During the postoperative period after repair, chronic PR is known to cause 
profuse diastolic filling of the RV with gradual dilation (81, 82). None of our 
patients reached the limit of 170 ml/m2 of RVEDV, which has been suggested 
as one of the operative thresholds for PVR(9, 117, 120).  
The clear relationship between PR and RV dilation was for the first time 
documented when Falliner et al. used video densitometry to quantify PR and 
established its relation to RV dilation(159). With CMR, the association 
between the degree of PR and RV size has been documented in previous 
studies(63, 160). Several authors have reported that the degree of PR 
independently predicted larger RV volume(161-163). Similar to our results 
(table 10), several other authors documented that the severity of PR had no 
effect on RV EF(63, 162-164). This finding has been contested by Lee et al., 
who reported a lower RV EF in patients with greater PR(165). 
6.2.2 LEFT VENTRICULAR PRELOADING, VOLUMES, AND 
FUNCTION
In study III we observed smaller LV end diastolic and stroke volumes in rTOF 
due to abnormal LV filling. The left atrial maximum volume, cyclic volume 
change, and conduit volume were smaller when compared to healthy controls.  
After repair necessitating TAP, profuse diastolic filling and RV dilation occur 
during follow-up due to PR (81, 82). These patients often present normal RV 
and LV functions (EFs) when they are evaluated by 2D ultrasound. However, 
the underlying disturbed postoperative pathophysiology and defective 
contractile reserve of the LV can be demonstrated with elaborate exercise-
based examinations (166). Therefore, in the late survivors of TOF population, 
as many as 20% have developed concurrent LV dysfunction.  It has even been 
suggested that this proportion could be as high as 70% with severe RV dilation. 
A progressive decline of LV function is a worrysome observation and an 
essential co-factor of patient deterioration that requires attention to improve 
late outcomes of TOF patients (71, 167). 
We conclude that left atrial function is impaired in our TOF patients despite 
successful surgical repair and approximately 12 years of recovery. The 
mechanism behind likely derives from severe PR reducing transpulmonary 
flow and left atrial filling and LV preload volume. We suggest that this leads to 
impediment of ventricular interaction, LV function and LV reserves. 
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6.2.3 MYOCARDIAL CINETICS 
6.2.3.1 CMR Feature Tracking 
CMR-FT is an emerging technique in assessing biventricular function with 
strain in rTOF patients. It offers several advantages when compared to MRI 
tagging, which is considered the gold standard method of measuring 
myocardial motion(101). CMR-FT is much less time consuming, does not 
require additional imaging sequences, and has better temporal resolution(101) 
when compared with myocardial tagging.  
We observed increased longitudinal strain in pediatric TOF patients with 
severe pulmonary regurgitation. In previous studies, LV longitudinal, 
circumferential, and radial strains were reduced when compared to healthy 
controls  (168-170). Similar to our findings, Berganza et al. used 2D CMR-FT 
and observed elevated RV circumferential strains and similar RV longitudinal 
strains of rTOF patients when compared to control subjects. Parallel to our 
study, their LV longitudinal strain was similar between patients and controls 
(171). We found no analysis of PR and its relation to CMR-FT findings in the 
recent literature, which is probably due to the novelty of the CMR-FT method. 
6.2.3.2 Segmental strain analysis
RVOT and the muscular surroundings of the VSD are affected during 
corrective surgery, regardless of the surgical method. Since superficial 
circumferential muscle fibres lie in parallel to these areas of manipulation, 
they are more likely to be injured than longitudinal fibres found especially in 
the free wall of the RV. It is thus possible that the apical part of the chamber 
left untouched during surgery could compensate for the reduced strain 
observed within regions subjected to injury. Our observation of increased RV 
apical circumferential strain in TOF patients further suggests that the 
deformation process serves as a compensatory mechanism. Anwar et al. 
reported diminished longitudinal strain of the RVOT after TAP when 
compared to pulmonary stenosis patients who were treated by balloon 
valvuloplasty(172). The authors proposed that the non-contractile TAP 
disturbing the RVOT contractions could explain this difference. Study IV 
revealed lower RV and LV EFs, which is consistent with this previous finding.  
 
The timing of both circumferential and longitudinal RV peak systolic strain 
was delayed in TOF patients. We suspect that this finding derives from right 
bundle branch block commonly observed after TOF repair. We also reported a 
faster return of LV longitudinal diastolic strain to baseline in patients with 
TOF than in healthy subjects. LV preload and stroke volume are decreased in 
TOF patients due to decreased transpulmonary flow induced by PR as reported 
in study III. It is possible that the diastolic phase of our patients was affected 
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by the smaller stroke volume and therefore the ventricle reached EDV faster 
than in control subjects. 
 
6.2.4 MYOCARDIAL FIBROSIS
6.2.4.1 LGE in rTOF patients
We observed LGE caused by reasons other than surgery in 39 of 40 TOF 
patients. LGE was not found in any of the control subjects. Severity of PR, the 
length of the post-operative time and RVEDV correlated positively to the LGE 
score. We conclude that RV myocardial LGE in remote areas of RV can be 
demonstrated already in young postoperative patients. Several authors have 
reported RV LGE as a marker of fibrosis in adult rTOF patients especially in 
RVOT, VSD patch region, and RV anterior wall (109, 173-175). Interestingly, 
LV LGE has been found in adult rTOF patients and this may be associated with 
adverse clinical outcomes(109, 175, 176). Similar to the findings published by 
Wald et al., we did not observe LV LGE among the present cohort of young 
rTOF patients. 
Chronic PR is likely important in the process, but other non-specific 
contributors, such as prolonged pre-operative cyanosis and perioperative or 
post-operative ischemic side effects, may be involved. Importantly, the LGE 
score had a positive correlation with the length of postoperative follow-up time 
(r=0.53, P=0.006; Figure 11C), suggesting the deleterious effect of long-lasting 
PR to the myocardium. A recent report has suggested that LGE in certain 
locations of myocardium predict SCD in dilated cardiomyopathy. Accordingly, 
these patients may benefit from an implantable cardioverter defibrillator. This 
further addresses the importance of LGE in the follow-up of adults with 
TOF(177). 
6.3 FUTURE PERSPECTIVES
Due to the excellent early and late results of surgery of TOF, the population of 
children, adolescents, and especially adults with TOF is increasing. A new 
population-based follow-up study after 10 to 15 years would extend the follow-
up time and give deeper insight in the changes of late prognosis after TOF 
surgery. In particular, these studies would elucidate the long-term results of 
patients repaired during the modern surgical era from the 1990s to the 
present. The oldest TOF patients are over 60 years and the course of the 
postoperative phase of TOF in the elderly remains to be studied as well(178). 
The Research Registry of Paediatric Cardiac Surgery and Finnish National 
Birth Registry would serve as an excellent base for a future study to assess 
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pregnancy outcomes of TOF and other CHD patients in a population-based 
setting.  
Although the postoperative course and the deleterious effect of PR are well 
established, many questions remain unanswered. PVR is often needed during 
adolescence after repair of TOF. The long-term viability of the implant valves 
is compromised and repetitious procedures are sometimes needed. Although 
such procedures are routine, risks are nevertheless involved. The correct 
timing of the PVR is also unresolved. Subjective symptoms and exercise 
capacity are not informative for timing of the first RVOT reconstructive 
re-operation, which makes these decisions more difficult (8). PVR should 
probably be performed before significant RV dilation. However, despite 
allowing favourable remodelling of the RV, no data has accumulated regarding 
whether PVR would improve survival.  
Big data is a term for very large and complex data sets beyond the 
calculation capacities of traditional data processing applications. Healthcare 
has benefited from big data analytics as it has provided for example clinical 
risk intervention and predictive analysis and broad patient- and 
organizational-level reporting of patient data(179). In the present study, large 
data sets of function, volume, kinetics, and myocardial structure of the RV, LV, 
and atria were collected. Combined with advanced data analytics and 
algorithms, new decision-making tools will likely emerge in TOF diagnostics. 
This may assist clinicians to effectively analyse large amounts of diverse 
patient information and could possibly improve decision making in daily 
practice.  
As a last perspective for the future, our patient cohort should be invited for 
a re-visit and repeat the study protocol of our initial study. This approach 
would provide insight in progression in postoperative TOF over time.  
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7 CONCLUSIONS
1. Primary repair of tetralogy of Fallot (TOF) reduces mortality and 
provides longer freedom from re-operation when compared to two-stage 
repair. Transannular patching had no effect on late mortality but carried a 
higher risk of redo procedures. Event-free survival of patients has significantly 
shortened from the 1970s to 2000s, since re-interventions were performed 
progressively earlier. This is probably due to improved diagnostic tools, more 
frequent polyclinical follow-up, and more active surgical treatment protocols. 
 
2. RV late gadolinium enhancement (LGE) is present in children 
after repair of TOF and also takes place outside surgically injured areas. The 
amount of LGE correlates with the severity of PR and RV dilation. 
 
3. Transpulmonary flow of patients with TOF is affected by an 
abundant PR leading to impediment of left atrial filling and defective LV 
preload volume. Our observation may be an important additional mechanism 
that disturbs ventricular interaction and contributes to late-onset dysfunction 
of the LV. 
4. Severe PR relates to enhanced longitudinal strain when compared 
to patients with milder regurgitation or to control subjects. TOF patients have 
a stronger gradual increase of RV circumferential strain from base to apex. 
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